Dlh awarded nih cancer epidemiology and genetics contract

Atlanta, july 11, 2022 (globe newswire) -- dlh holdings corp. (nasdaq: dlhc) (“dlh” or the “company”), a leading provider of innovative health research services and solutions to federal agencies, today announced that its subsidiary social & scientific systems, inc. has been awarded an indefinite delivery/indefinite quantity (id/iq) multiple award contract to provide support to the national cancer institute's (“nci”) division of cancer epidemiology and genetics (“dceg”). nci is an institute of the national institutes of health (“nih”) dedicated to leading, conducting, and supporting cancer research across the nation with the aim of advancing scientific knowledge and prolonging human lives.
DLHC Ratings Summary
DLHC Quant Ranking